WVU Cancer Institute’s Dr. Ivan Martinez and his lab will engage in collaborative research with their colleagues at The German Primate Center, part of the Gottingen University-Max Planck Institutes in Germany, later this year.
Dr. Martinez’s research on the role of RNAs in cancer development piqued the interest of Dr. Jens Gruber, professor at The Primate Center and his graduate student Nicolas Lemus, and they invited Martinez to their country recently to give a couple talks about his work at the Cancer Institute. They were especially interested in Martinez’s project related to the discovery of an alternative pathway of microRNA biogenesis. Part of this project was recently published in the Journal Proceedings of the National Academy of Sciences (PNAS, 2017).
MicroRNAs are small RNA molecules that are very important in the regulation of genes in normal and cancer cells. MicroRNA biogenesis is a process by which these molecules form, reshape and become active in cells. Martinez’s lab discovered a different microRNA biogenesis process in dormant cells, meaning cells that are in a “resting” or “quiescent” state. This discovery is important in the cancer field because understanding in detail this new process could help develop new treatments against dormant cancer stem cells, which are known to be more resistant to cancer therapy and responsible for cancer relapse.
“Nicolas Lemus found our publication on PubMed and realized that our data were the “missing link” that clarified his experimental findings,” Martinez said. “My German colleagues were very happy because our publication helped them put together a better story of their data.”
The collaboration between Gottingen University and the WVU Cancer Institute will begin with a three-month visit by Lemus to the Cancer Institute to learn how to develop specific techniques established in Martinez’s laboratory.
Defense Health Program
The WVU Cancer Institute is applying for a Certificate of Need with the West Virginia Health Care Authority for a mobile lung cancer screening program, which will be called LUCAS. This program would increase access to screening for patients in rural areas and address the growing demand for cancer services in the state.
WVU Medicine Physician Presents at International Society of Intraoperative Radiation Therapy Conference
Christopher P. Cifarelli, M.D., Ph.D., Director of the WVU Medicine Gamma Knife program and member of the WVU Cancer Institute Research Programs, presented a talk on his team’s research during the 2018 ISIORT conference in Mannheim, Germany. Dr. Cifarelli presented two sessions: Feasibility of Dose Escalation Using Intraoperative Radiotherapy Following Resection of Large Brain Metastases Compared to Post-operative SRS and Neurosurgical Nuances of IORT for Intracranial Lesions. The work focuses on a novel use of radiation delivered to the brain at the time of surgery as a means to decrease long-term radiation doses and improve overall outcomes for patients with metastatic and primary brain tumors. The conference had about 300 specialists from over 20 nations in attendance. Dr. Cifarelli is a faculty member in the WVU Department of Neurosurgery and a member of the Radiation Oncology team at WVU Cancer Institute. This work was co-authored by Joshua Hack MS, Geraldine M. Jacobson MD, and J. Austin Vargo MD.